Interferon and Natural Killer Cell Activity in Multiple Sclerosis
Author Information
Author(s): S. B. Cheknev, Y. G. Ashmanova, A. D. Pritsker, O. L. Latysheva, F. I. Yershov, A. J. Kulberg
Primary Institution: N. F. Gamaleya Institute for Epidemiology and Microbiology of the Russian Academy of Medical Sciences
Hypothesis
The study investigates the effects of autologous interferon on the natural killer cell activity of peripheral blood lymphocytes in patients with multiple sclerosis compared to healthy donors.
Conclusion
Autologous interferon significantly enhances natural killer cell activity in patients with multiple sclerosis, unlike in healthy donors.
Supporting Evidence
- Interferon did not enhance natural killer activity in healthy donors.
- Patients with multiple sclerosis showed a significant increase in natural killer activity after interferon treatment.
- The study suggests the presence of an inhibitor of interferon action in healthy donors that is absent in MS patients.
Takeaway
This study found that interferon helps boost the immune cells that fight infections in people with multiple sclerosis, but not in healthy people.
Methodology
The study involved six healthy donors and ten patients with multiple sclerosis, measuring the natural killer activity of peripheral blood lymphocytes after treatment with autologous interferon.
Limitations
The study used a small sample size and focused only on specific types of interferon.
Participant Demographics
Six healthy donors (2 men, 4 women) aged 18-48 years; ten MS patients (4 men, 6 women) aged 18-42 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website